Evidence map›Paper›PMID 39872062›Full record

ReviewLife medicine2023

Advancements in robotic arm-based 3D bioprinting for biomedical applications.

Kai Li, WenHui Huang, HaiTao Guo, YanYan Liu, Shuxian Chen, Heng Liu, Qi Gu

Abstract readReview
In one paragraph

Review in Life medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. ReBiA-Robotic Enabled Biological Automation: 3D Epithelial Tissue Production.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kai LiState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
WenHui HuangState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
HaiTao GuoState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
YanYan LiuSchool of Materials Design and Engineering, Beijing Institute of Fashion Technology, Beijing 100029, China.
Shuxian ChenState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Heng LiuState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Qi GuState Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.ORCID https://orcid.org/0000-0001-9387-9525

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

3D bioprinting emerges as a critical tool in biofabricating functional 3D tissue or organ equivalents for regenerative medicine. Bioprinting techniques have been making strides in integrating automation, customization, and digitalization in coping with diverse tissue engineering scenarios. The convergence of robotic arm-based 3D bioprinting techniques, especially

Indexed as

3D bioprintinghydrogelin situ bioprintingrobot arm-based bioprintingtissue engineering

Identifiers

PMID39872062
PMCPMC11749708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.